How govt incentives fuelled growth in cancer drug industry
The NBR has exempted cancer drug production from VAT and waived import duties on raw materials and machinery, making it cheaper for companies to manufacture oncology drugs domestically.
The NBR has exempted cancer drug production from VAT and waived import duties on raw materials and machinery, making it cheaper for companies to manufacture oncology drugs domestically.